Epidemiology of psychosis in Parkinson's disease
暂无分享,去创建一个
[1] G. Wooten,et al. Prospective study of hallucinations and delusions in Parkinson's disease , 2001, Journal of neurology, neurosurgery, and psychiatry.
[2] K. Marder,et al. The association of incident dementia with mortality in PD , 2002, Neurology.
[3] Jian Wang,et al. Cholecystokinin, cholecystokinin-A receptor and cholecystokinin-B receptor gene polymorphisms in Parkinson's disease. , 2003, Pharmacogenetics.
[4] S. Leurgans,et al. Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's disease , 1999, Movement disorders : official journal of the Movement Disorder Society.
[5] Enrico Marchioni,et al. Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease , 2005, Movement disorders : official journal of the Movement Disorder Society.
[6] W. Poewe,et al. Practice Parameter: Evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology , 2006, Neurology.
[7] J. Morris,et al. Clinical phenotype of Parkinson disease dementia , 2006, Neurology.
[8] K. Aitchison,et al. Association study of dopamine receptor gene polymorphisms with drug-induced hallucinations in patients with idiopathic Parkinson's disease. , 2000, Pharmacogenetics.
[9] J. Friedman,et al. Efficacy of pramipexole, a novel dopamine agonist, as monotherapy in mild to moderate Parkinson's disease , 1997, Neurology.
[10] C. Goetz,et al. Hallucinations in Parkinson disease in the prelevodopa era , 2006, Neurology.
[11] N. Kumar,et al. The Sydney Multicenter Study of Parkinson's Disease: The Inevitability of Dementia at 20 years , 2009 .
[12] P J Feustel,et al. Longitudinal outcome of Parkinson’s disease patients with psychosis , 2003, Neurology.
[13] L. Murri,et al. Visual hallucinations in Parkinson's disease are not influenced by polymorphisms of serotonin 5-HT2A receptor and transporter genes , 2007, Neuroscience Letters.
[14] S. Leurgans,et al. Hallucinations and sleep disorders in PD , 2005, Neurology.
[15] R. Grünewald,et al. Hallucinosis in idiopathic Parkinson’s disease , 1997, Journal of neurology, neurosurgery, and psychiatry.
[16] S. Leurgans,et al. Genetic variation analysis in parkinson disease patients with and without hallucinations: case-control study. , 2001, Archives of neurology.
[17] N. Newman,et al. Ophthalmologic features of Parkinson’s disease , 2004, Neurology.
[18] C. White,et al. Dopamine agonists in the treatment of early Parkinson's disease: a meta-analysis. , 2009, Parkinsonism & related disorders.
[19] S. Factor,et al. Parkinson's disease: drug-induced psychiatric states. , 1995, Advances in neurology.
[20] K. Chaudhuri,et al. Non-motor symptoms of Parkinson's disease: diagnosis and management , 2006, The Lancet Neurology.
[21] C. Peretz,et al. Antiparkinsonian medication is not a risk factor for the development of hallucinations in Parkinson’s disease , 2004, Journal of Neural Transmission.
[22] Nir Giladi,et al. Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease , 2000, Journal of Neural Transmission.
[23] K. Nakashima,et al. Clinical evaluation of Parkinson’s disease dementia: association with aging and visual hallucination , 2007, Acta neurologica Scandinavica.
[24] Biao Chen,et al. Polymorphisms of dopamine receptor and transporter genes and hallucinations in Parkinson's disease , 2004, Neuroscience Letters.
[25] J. Friedman,et al. The management of the levodopa psychoses. , 1991, Clinical neuropharmacology.
[26] A. Lees,et al. Using the presence of visual hallucinations to differentiate Parkinson’s disease from atypical parkinsonism , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.
[27] J. Sanchez-Ramos,et al. Visual hallucinations associated with Parkinson disease. , 1996, Archives of neurology.
[28] E. Wolters,et al. Mental dysfunction in Parkinson's disease. , 1998, Parkinsonism & related disorders.
[29] F. Goodwin. Psychiatric side effects of levodopa in man. , 1971, JAMA.
[30] C. Tanner,et al. Levodopa and the progression of Parkinson's disease. , 2004, The New England journal of medicine.
[31] H. Katzen,et al. A questionnaire-based (UM-PDHQ) study of hallucinations in Parkinson's disease , 2008, BMC neurology.
[32] G. Fénelon. Psychosis in Parkinson's Disease: Phenomenology, Frequency, Risk Factors, and Current Understanding of Pathophysiologic Mechanisms , 2008, CNS Spectrums.
[33] S. Leurgans,et al. The malignant course of "benign hallucinations" in Parkinson disease. , 2006, Archives of neurology.
[34] G. Stebbins,et al. Risk factors for nursing home placement in advanced Parkinson's disease , 1993, Neurology.
[35] S. Grill,et al. Psychiatric comorbidities in patients with Parkinson disease and psychosis , 2004, Neurology.
[36] W. Weiner,et al. Sleep Disruption in the Course of Chronic Levodopa Therapy: An Early Feature of the Levodopa Psychosis , 1982, Clinical neuropharmacology.
[37] J. Cummings,et al. Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study. , 1999, Archives of neurology.
[38] Akiko Tamura,et al. Impaired Visual Acuity as a Risk Factor for Visual Hallucinations in Parkinson’s Disease , 2006, Journal of geriatric psychiatry and neurology.
[39] A. Korczyn,et al. Auditory hallucinations in Parkinson’s disease , 1998, Journal of neurology, neurosurgery, and psychiatry.
[40] S. Leurgans,et al. Antipsychotic medication treatment for mild hallucinations in Parkinson's disease: Positive impact on long‐term worsening , 2008, Movement disorders : official journal of the Movement Disorder Society.
[41] S. Leurgans,et al. Poor visual discrimination and visual hallucinations in Parkinson's disease. , 1998, Clinical neuropharmacology.
[42] G. Fénelon,et al. Hallucinations in Parkinson's disease: A follow‐up study , 2005, Movement disorders : official journal of the Movement Disorder Society.
[43] S. Leurgans,et al. Genetic polymorphisms in Parkinson disease subjects with and without hallucinations: an analysis of the cholecystokinin system. , 2004, Archives of neurology.
[44] C. Tanner,et al. Early dopaminergic drug-induced hallucinations in parkinsonian patients , 1998, Neurology.
[45] S. Papapetropoulos,et al. Factors associated with drug–induced visual hallucinations in Parkinson's disease , 2005, Journal of Neurology.
[46] David R Williams,et al. Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study , 2005, The Lancet Neurology.
[47] S. Leurgans,et al. Prospective longitudinal assessment of hallucinations in Parkinson’s disease , 2001, Neurology.
[48] A. Schrag. Psychiatric aspects of Parkinson's disease--an update. , 2004, Journal of neurology.
[49] I. Gottesman,et al. Correlates of hallucinations in schizophrenia: A cross‐cultural evaluation , 2007, Schizophrenia Research.
[50] D. Kömpf,et al. A study of visual hallucinations in patients with Parkinson’s disease , 1997, Journal of Neurology.
[51] Uwe Siebert,et al. Rate of clinical progression in Parkinson's disease. A prospective study , 2007, Movement disorders : official journal of the Movement Disorder Society.
[52] W. Weiner,et al. Practice Parameter: Evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology , 2006, Neurology.
[53] M Emre,et al. Neuropsychiatric symptoms in patients with Parkinson’s disease and dementia: frequency, profile and associated care giver stress , 2006, Journal of Neurology, Neurosurgery & Psychiatry.
[54] G. Fénelon,et al. Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. , 2000, Brain : a journal of neurology.
[55] G. Stebbins,et al. Mortality and hallucinations in nursing home patients with advanced Parkinson's disease , 1995, Neurology.
[56] D. Paleacu,et al. Association between family history of dementia and hallucinations in Parkinson disease , 2005, Neurology.
[57] A. David,et al. Visual hallucinations in Parkinson's disease: a review and phenomenological survey , 2001, Journal of neurology, neurosurgery, and psychiatry.
[58] M. Onofrj,et al. HLA typing does not predict REM sleep behaviour disorder and hallucinations in Parkinson's disease , 2003, Movement disorders : official journal of the Movement Disorder Society.
[59] W. Poewe,et al. Scales to assess psychosis in Parkinson's disease: Critique and recommendations , 2008, Movement disorders : official journal of the Movement Disorder Society.
[60] P. Moberg,et al. Frequency and correlates of co-morbid psychosis and depression in Parkinson's disease. , 2006, Parkinsonism & related disorders.
[61] P. Hobson,et al. Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom , 2004, Movement disorders : official journal of the Movement Disorder Society.
[62] S. Papapetropoulos. Drug-induced psychosis in Parkinson disease: phenomenology and correlations among psychosis rating instruments. , 2006, Clinical neuropharmacology.
[63] Yoav Ben-Shlomo,et al. How common are complications of Parkinson's disease? , 2002, Journal of Neurology.
[64] G. Albani,et al. Visual hallucinations in Parkinson's disease: Clues to separate origins , 2006, Journal of the Neurological Sciences.
[65] K. Gwinn‐Hardy,et al. Diagnostic criteria for psychosis in Parkinson's disease: Report of an NINDS, NIMH work group , 2007, Movement disorders : official journal of the Movement Disorder Society.
[66] M. Mcdermott,et al. Risk factors for somnolence, edema, and hallucinations in early Parkinson disease , 2007, Neurology.
[67] D. Aarsland,et al. Predictors of Nursing Home Placement in Parkinson's Disease: A Population‐Based, Prospective Study , 2000, Journal of the American Geriatrics Society.
[68] D. Aarsland,et al. The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson’s disease , 2009, Journal of Neurology, Neurosurgery, and Psychiatry.
[69] I. McKeith,et al. A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia , 2001, International journal of geriatric psychiatry.